Small pharmaceutical firms to be shaken by new GMP policy

Published: 2007-10-02 06:58:00

Updated: 2007-10-02 06:58:00

Small- and medium-sized companies are worried about financial pinch due to planned implementation of a new current good manufacturing practice (cGMP) system and validation from next year.

Last year, the Food and Drug Administration (KFDA) announced the new cGMP regulations by phase in a bid to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK